These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 11220986

  • 1. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA.
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [Abstract] [Full Text] [Related]

  • 2. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W, Raz R, Colodner R, Keness Y.
    Harefuah; 1997 Nov 02; 133(9):365-6, 414. PubMed ID: 9418339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A.
    Int J Antimicrob Agents; 2004 Sep 02; 24(3):290-3. PubMed ID: 15325435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z, Baysallar M, Gür D, Doğanci L.
    Mikrobiyol Bul; 2003 Oct 02; 37(4):225-34. PubMed ID: 14748258
    [Abstract] [Full Text] [Related]

  • 7. Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes.
    Drago L, Ripa S, Zampaloni C, De Vecchi E, Vitali LA, Petrelli D, Prenna M.
    Chemotherapy; 2005 Aug 02; 51(5):268-71. PubMed ID: 16088124
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD, Rybak MJ.
    J Antimicrob Chemother; 2004 Aug 02; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
    Liu X, Shen X, Chang H, Huang G, Fu Z, Zheng Y, Wang L, Li C, Liu L, Shen Y, Yang Y.
    Pediatr Pulmonol; 2009 May 02; 44(5):436-41. PubMed ID: 19360846
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
    Gracia M, Díaz C, Coronel P, Gimeno M, García-Rodas R, Rodríguez-Cerrato V, del Prado G, Huelves L, Ruiz V, Naves PF, Ponte MC, Granizo JJ, Soriano F.
    Diagn Microbiol Infect Dis; 2009 May 02; 64(1):52-6. PubMed ID: 19232860
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.